Solid tumors exist in a hypoxic microenvironment, and possess high-glycolytic metabolites. To avoid the acidosis, tumor cells must exhibit a dynamic cytosolic pH regulation mechanism(s). The voltage-gated proton channel Hv1 mediates NADPH oxidase function by compensating cellular loss of electrons with protons. Here, we showed for the first time, that Hv1 expression is increased in colorectal tumor tissues and cell lines, associated with poor prognosis. Immunohistochemistry showed that Hv1 is strongly expressed in adenocarcinomas but not or lowly expressed in normal colorectal or hyperplastic polyps. Hv1 expression in colorectal cancer is significantly associated with the tumor size, tumor classification, lymph node status, clinical stage and p53 status. High Hv1 expression is associated significantly with shorter overall and recurrence-free survival. Furthermore, real-time RT-PCR and immunocytochemistry showed that Hv1 is highly expressed in colorectal cancer cell lines, SW620, HT29, LS174T and Colo205, but not in SW480. Inhibitions of Hv1 expression and activity in the highly metastatic SW620 cells by small interfering RNA (siRNA) and Zn2+ respectively, markedly decrease the cell invasion and migration, restraint proton extrusion and the intracellular pH recovery. Our results suggest that Hv1 may be used as a potential biomarker for diagnosis and prognosis of colorectal carcinoma, and a potential target for anticancer drugs in colorectal cancer therapy.
References
[1]
Ramsey IS, Moran MM, Chong JA, Clapham DE (2006) A voltage-gated proton-selective channel lacking the pore domain. Nature 440: 1213–1216.
[2]
Sasaki M, Takagi M, Okamura Y (2006) A voltage sensor-domain protein is a voltage-gated proton channel. Science 312: 589–592.
[3]
DeCoursey TE (2006) Voltage-gated proton channels and other proton transfer pathways. Physiol Rev 83: 475–579.
[4]
Henderson LM, Chappell JB, Jones OT (1987) The superoxide-generating NADPH oxidase of human neutrophils is electrogenic and associated with an H+ channel. Biochem J 246: 325–329.
[5]
Clark RA, Leidal KG, Pearson DW, Nauseef WM (1987) NADPH oxidase of human neutrophils. Subcellular localization and characterization of an arachidonate-activatable superoxide-generating system. J Biol Chem 262: 4065–4074.
[6]
Morgan D, Cherny VV, Murphy R, Katz BZ, DeCoursey TE (2005) The pH dependence of NADPH oxidase in human eosinophils. J Physiol 569: 419–431.
Cherny VV, Markin VS, DeCoursey TE (1995) The voltage-activated hydrogen ion conductance in rat alveolar epithelial cells is determined by the pH gradient. J Gen Physiol 105: 861–896.
[9]
Cherny VV, DeCoursey TE (1999) pH-dependent inhibition of voltage-gated H(+) currents in rat alveolar epithelial cells by Zn(2+) and other divalent cations. J Gen Physiol 114: 819–838.
[10]
Long SB, Campbell EB, Mackinnon R (2005) Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science 309: 897–903.
[11]
Koch HP, Kurokawa T, Okochi Y, Sasaki M, Okamura Y, et al. (2008) Multimeric nature of voltage-gated proton channels. Proc Natl Acad Sci USA 105: 9111–9116.
[12]
Tombola F, Ulbrich MH, Isacoff EY (2008) The voltage-gated proton channel Hv1 has two pores, each controlled by one voltage sensor. Neuron 58: 546–556.
[13]
Lee SY, Letts JA, Mackinnon R (2008) Dimeric subunit stoichiometry of the human voltage-dependent proton channel Hv1. Proc Natl Acad Sci USA 105: 7692–7695.
[14]
Li SJ, Zhao Q, Zhou Q, Unno H, Zhai Y, et al. (2010) The role and structure of the carboxyl-terminal domain of the human voltage-gated proton channel Hv1. J Biol Chem 285: 12047–12054.
[15]
Fais S, De Milito A, You H, Qin W (2007) Targeting vacuolar H+-ATPases as a new strategy against cancer. Cancer Res 67: 10627–10630.
[16]
Racker E (1972) Bioenergetics and the problem of tumor growth. Am Sci 60: 56–63.
[17]
Wang Y, Li SJ, Pan J, Che Y, Yin J, et al. (2011) Specific expression of the human voltage-gated proton channel Hv1 in highly metastatic breast cancer cells, promotes tumor progression and metastasis. Biochem Biophys Res Commun 412(2): 353–359.
[18]
Wang Y, Li SJ, Wu X, Che Y, Li Q (2012) Clinicopathological and biological significance of human voltage-gated proton channel Hv1 protein overexpression in breast cancer. J Biol Chem 87(17): 13877–13888.
[19]
Li SJ, Zhao Q, Zhou Q, Zhai Y (2009) Expression, purification, crystallization and preliminary crystallographic study of the carboxyl-terminal domain of the human voltage-gated proton channel Hv1. Acta Crystallogr F65: 279–281.
[20]
Chiche J, Ilc K, Laferrière J, Trottier E, Dayan F, et al. (2009) Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res 69: 358–368.
[21]
Nilsson C, K？gedal K, Johansson U, Ollinger K (2003) Analysis of cytosolic and lysosomal pH in apoptotic cells by flow cytometry. Methods Cell Sci 25: 185–194.
[22]
Griffiths JR (1991) Are cancer cells acidic? Br J Cancer 64: 425–427.
[23]
Gillies RJ, Liu Z, Bhujwalla Z (1994) 31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. Am J Physiol 267: C195–C203.
[24]
Raghunand N, Martínez-Zaguila′n R, Wright SH, Gillies RJ (1999) pH and drug resistance. II. Turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs. Biochem Pharmacol 57: 1047–1058.
[25]
Gottlieb RA, Giesing HA, Zhu JY, Engler RL, Babior BM (1995) Cell acidification in apoptosis: granulocyte colony-stimulating factor delays programmed cell death in neutrophils by up-regulating the vacuolar H+-ATPase. Proc Natl Acad Sci USA 92: 5965–5968.
[26]
Pouyssegur J, Sardet C, Franchi A, L′Allemain G, Paris S (1984) A specific mutation abolishing Na+/H+ antiport activity in hamster fibroblasts precludes growth at neutral and acidic pH. Proc Natl Acad Sci USA 81: 4833–4837.
[27]
Gillies RJ, Martinez-Zaguilan R (1991) Regulation of intracellular pH in BALB/c-3T3 cells: bicarbonate raises pH via NaHCO3/HCl exchange and attenuates the activation of Na+/H+ exchange by serum. J Biol Chem 266: 1551–1556.
[28]
Huber V, De Milito A, Harguindey S, Reshkin SJ, Wahl ML, et al. (2010) Proton dynamics in cancer. J Transl Med 8: 57.
[29]
Cardone RA, Casavola V, Reshkin SJ (2005) The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nat Rev Cancer 5: 786–795.
[30]
Neri D, Supuran CT (2011) Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 10: 767–777.
[31]
Parks SK, Chiche J, Pouyssegur J (2010) pH control mechanisms of tumor survival and growth. J Cell Physiol 226: 299–308.
[32]
Lu X, Qin W, Li J, Tan N, Pan D, et al. (2005) The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump. Cancer Res 65: 6843–6849.
[33]
Fais S (2010) Proton pump inhibitor-induced tumor cell death by inhibition of a detoxification mechanism. . J Intern Med. 267: 515–525.
[34]
Luciani F, Spada M, De Milito A, Molinari A, Rivoltini L, et al. (2004) Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst 96: 1702–1713.
[35]
De Milito A, Iessi E, Logozzi MA, Lozupone F, Spada M, et al. (2007) Proton pump inhibitors induce apoptosis of human B cell tumors through a caspase-independent mechanism involving reactive oxygen species. Cancer Res 67: 5408–5417.
[36]
De Milito A, Canese R, Marino ML, Borghi M, Iero M, et al. (2010) pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int J Cancer 127: 207–219.
[37]
Iovannisci D, Illek B, Fischer H (2010) Function of the HVCN1 proton channel in airway epithelia and a naturally occurring mutation, M91T. J Gen Physiol 136: 35–46.
[38]
Gatenby RA, Gawlinski ET (2003) The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. Cancer Res 63: 3847–3854.
